JEFFREY M LEIDEN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JEFFREY M LEIDEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JEFFREY M LEIDEN. JEFFREY M LEIDEN is President & COO in ABBOTT LABORATORIES ($ABT) and President and COO in ABBOTT LABORATORIES ($ABT) and CEO & President in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Executive Chairman in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in QUEST DIAGNOSTICS INC ($DGX).
Latest Insider Trading Transactions of JEFFREY M LEIDEN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABT, DGX, VRTX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Payment of Exercise | F | 215.03 | 8,599 | 1,849,043 | 77,600 | 86.2 K to 77.6 K (-9.98 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Grant | A | 0.00 | 20,928 | 0 | 86,199 | 65.3 K to 86.2 K (+32.06 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Grant | A | 0.00 | 31,462 | 0 | 65,271 | 33.8 K to 65.3 K (+93.06 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Grant | A | 0.00 | 31,498 | 0 | 33,809 | 2.3 K to 33.8 K (+1,362.96 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Payment of Exercise | F | 215.03 | 8,599 | 1,849,043 | 77,600 | 86.2 K to 77.6 K (-9.98 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Grant | A | 0.00 | 20,928 | 0 | 86,199 | 65.3 K to 86.2 K (+32.06 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Grant | A | 0.00 | 31,462 | 0 | 65,271 | 33.8 K to 65.3 K (+93.06 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Grant | A | 0.00 | 31,498 | 0 | 33,809 | 2.3 K to 33.8 K (+1,362.96 %) |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Option Exercise | M | 155.57 | 24,349 | 3,787,974 | 24,348 | |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Option Exercise | M | 91.05 | 4,470 | 406,994 | 98,336 | |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Option Exercise | M | 96.87 | 35,499 | 3,438,788 | 35,499 | |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Option Exercise | M | 187.53 | 24,216 | 4,541,226 | 24,215 | |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Sell | S | 272.41 | 5,607 | 1,527,403 | 40,821 | 46.4 K to 40.8 K (-12.08 %) |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Sell | S | 271.61 | 14,131 | 3,838,121 | 46,428 | 60.6 K to 46.4 K (-23.33 %) |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Sell | S | 270.43 | 13,885 | 3,754,921 | 60,559 | 74.4 K to 60.6 K (-18.65 %) |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Sell | S | 269.52 | 30,237 | 8,149,476 | 74,444 | 104.7 K to 74.4 K (-28.88 %) |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Sell | S | 268.63 | 24,617 | 6,612,865 | 104,681 | 129.3 K to 104.7 K (-19.04 %) |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Sell | S | 267.52 | 5,892 | 1,576,228 | 129,298 | 135.2 K to 129.3 K (-4.36 %) |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Buy | M | 155.57 | 24,349 | 3,787,974 | 135,190 | 110.8 K to 135.2 K (+21.97 %) |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Buy | M | 91.05 | 4,470 | 406,994 | 110,841 | 106.4 K to 110.8 K (+4.20 %) |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Buy | M | 96.87 | 35,499 | 3,438,788 | 106,371 | 70.9 K to 106.4 K (+50.09 %) |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Buy | M | 187.53 | 24,216 | 4,541,226 | 70,872 | 46.7 K to 70.9 K (+51.90 %) |
| Apr 02 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Payment of Exercise | F | 234.01 | 40,090 | 9,381,461 | 52,491 | 92.6 K to 52.5 K (-43.30 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 238.33 | 1,680 | 400,394 | 92,581 | 94.3 K to 92.6 K (-1.78 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 236.63 | 560 | 132,513 | 94,261 | 94.8 K to 94.3 K (-0.59 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 235.53 | 1,210 | 284,991 | 94,821 | 96 K to 94.8 K (-1.26 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 234.49 | 1,640 | 384,564 | 96,031 | 97.7 K to 96 K (-1.68 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 232.96 | 1,017 | 236,920 | 97,671 | 98.7 K to 97.7 K (-1.03 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 231.76 | 1,050 | 243,348 | 98,688 | 99.7 K to 98.7 K (-1.05 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 230.40 | 1,120 | 258,048 | 99,738 | 100.9 K to 99.7 K (-1.11 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 229.77 | 2,273 | 522,267 | 100,858 | 103.1 K to 100.9 K (-2.20 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Payment of Exercise | F | 239.23 | 8,410 | 2,011,924 | 103,131 | 111.5 K to 103.1 K (-7.54 %) |
| Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 248.45 | 4,609 | 1,145,106 | 132,540 | 137.1 K to 132.5 K (-3.36 %) |
| Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 247.49 | 7,533 | 1,864,342 | 137,149 | 144.7 K to 137.1 K (-5.21 %) |
| Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 246.27 | 14,433 | 3,554,415 | 144,682 | 159.1 K to 144.7 K (-9.07 %) |
| Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 245.37 | 14,024 | 3,441,069 | 159,115 | 173.1 K to 159.1 K (-8.10 %) |
| Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 244.56 | 4,124 | 1,008,565 | 173,139 | 177.3 K to 173.1 K (-2.33 %) |
| Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 243.37 | 2,800 | 681,436 | 177,263 | 180.1 K to 177.3 K (-1.56 %) |
| Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Payment of Exercise | F | 240.95 | 36,755 | 8,856,117 | 180,063 | 216.8 K to 180.1 K (-16.95 %) |
| Nov 21 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 131.89 | 32,502 | 4,286,689 | 0 | |
| Nov 21 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 109.14 | 64,032 | 6,988,452 | 0 | |
| Nov 21 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 212.75 | 10,615 | 2,258,341 | 106,346 | 117 K to 106.3 K (-9.08 %) |
| Nov 21 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 211.43 | 23,033 | 4,869,867 | 116,961 | 140 K to 117 K (-16.45 %) |
| Nov 21 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 210.41 | 62,886 | 13,231,843 | 139,994 | 202.9 K to 140 K (-31.00 %) |
| Nov 21 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 131.89 | 32,502 | 4,286,689 | 202,880 | 170.4 K to 202.9 K (+19.08 %) |
| Nov 21 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 109.14 | 64,032 | 6,988,452 | 170,378 | 106.3 K to 170.4 K (+60.21 %) |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 131.89 | 1,493 | 196,912 | 32,502 | |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 109.14 | 2,941 | 320,981 | 64,032 | |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 131.89 | 1,683 | 221,971 | 33,995 | |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 109.14 | 3,317 | 362,017 | 66,973 | |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 210.00 | 1,493 | 313,530 | 106,346 | 107.8 K to 106.3 K (-1.38 %) |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 131.89 | 1,493 | 196,912 | 107,839 | 106.3 K to 107.8 K (+1.40 %) |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 210.00 | 2,941 | 617,610 | 106,346 | 109.3 K to 106.3 K (-2.69 %) |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 109.14 | 2,941 | 320,981 | 109,287 | 106.3 K to 109.3 K (+2.77 %) |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 210.00 | 1,683 | 353,430 | 106,346 | 108 K to 106.3 K (-1.56 %) |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 131.89 | 1,683 | 221,971 | 108,029 | 106.3 K to 108 K (+1.58 %) |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 210.00 | 3,317 | 696,570 | 106,346 | 109.7 K to 106.3 K (-3.02 %) |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 109.14 | 3,317 | 362,017 | 109,663 | 106.3 K to 109.7 K (+3.12 %) |
| Oct 24 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 131.89 | 35,411 | 4,670,357 | 71,089 | |
| Oct 24 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 109.14 | 72,420 | 7,903,919 | 140,580 | |
| Oct 24 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 190.00 | 35,411 | 6,728,090 | 106,287 | 141.7 K to 106.3 K (-24.99 %) |
| Oct 24 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 131.89 | 35,411 | 4,670,357 | 141,698 | 106.3 K to 141.7 K (+33.32 %) |
| Oct 24 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 190.00 | 72,420 | 13,759,800 | 106,287 | 178.7 K to 106.3 K (-40.52 %) |
| Oct 24 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 109.14 | 72,420 | 7,903,919 | 178,707 | 106.3 K to 178.7 K (+68.14 %) |
| Jun 20 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 77.31 | 56,030 | 4,331,679 | 0 | |
| Jun 20 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 176.11 | 4,249 | 748,291 | 106,287 | 110.5 K to 106.3 K (-3.84 %) |
| Jun 20 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 175.33 | 51,781 | 9,078,763 | 110,536 | 162.3 K to 110.5 K (-31.90 %) |
| Jun 20 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 77.31 | 56,030 | 4,331,679 | 162,317 | 106.3 K to 162.3 K (+52.72 %) |
| May 28 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 77.31 | 113,432 | 8,769,428 | 56,030 | |
| May 28 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 175.10 | 113,432 | 19,861,943 | 106,287 | 219.7 K to 106.3 K (-51.63 %) |
| May 28 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 77.31 | 113,432 | 8,769,428 | 219,719 | 106.3 K to 219.7 K (+106.72 %) |
| May 08 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 77.31 | 2,300 | 177,813 | 169,462 | |
| May 08 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 77.31 | 30,758 | 2,377,901 | 171,762 | |
| May 08 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 175.02 | 2,300 | 402,546 | 106,195 | 108.5 K to 106.2 K (-2.12 %) |
| May 08 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 77.31 | 2,300 | 177,813 | 108,495 | 106.2 K to 108.5 K (+2.17 %) |
| May 08 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 175.01 | 30,758 | 5,382,958 | 106,195 | 137 K to 106.2 K (-22.46 %) |
| May 08 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 77.31 | 30,758 | 2,377,901 | 136,953 | 106.2 K to 137 K (+28.96 %) |
| May 03 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 77.31 | 300 | 23,193 | 202,520 | |
| May 03 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 77.31 | 10,180 | 787,016 | 202,820 | |
| May 03 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 175.04 | 300 | 52,512 | 106,195 | 106.5 K to 106.2 K (-0.28 %) |
| May 03 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 77.31 | 300 | 23,193 | 106,495 | 106.2 K to 106.5 K (+0.28 %) |
| May 03 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 175.08 | 10,180 | 1,782,314 | 106,195 | 116.4 K to 106.2 K (-8.75 %) |
| May 03 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 77.31 | 10,180 | 787,016 | 116,375 | 106.2 K to 116.4 K (+9.59 %) |
| Feb 21 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 188.61 | 1,200 | 226,332 | 106,195 | 107.4 K to 106.2 K (-1.12 %) |
| Feb 21 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 187.43 | 2,700 | 506,061 | 107,395 | 110.1 K to 107.4 K (-2.45 %) |
| Feb 21 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 186.80 | 17,097 | 3,193,720 | 110,095 | 127.2 K to 110.1 K (-13.44 %) |
| Feb 08 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | A | 187.53 | 72,647 | 13,623,492 | 72,647 | |
| Feb 08 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Grant | A | 0.00 | 28,444 | 0 | 238,623 | 210.2 K to 238.6 K (+13.53 %) |
| Feb 08 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Grant | A | 0.00 | 31,498 | 0 | 210,179 | 178.7 K to 210.2 K (+17.63 %) |
| Feb 08 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Grant | A | 0.00 | 53,816 | 0 | 178,681 | 124.9 K to 178.7 K (+43.10 %) |
| Feb 06 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 187.91 | 900 | 169,119 | 124,865 | 125.8 K to 124.9 K (-0.72 %) |
| Feb 06 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 186.70 | 12,951 | 2,417,952 | 125,765 | 138.7 K to 125.8 K (-9.34 %) |
| Feb 06 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 186.10 | 17,099 | 3,182,124 | 138,716 | 155.8 K to 138.7 K (-10.97 %) |
| Feb 06 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 184.99 | 1,300 | 240,487 | 155,815 | 157.1 K to 155.8 K (-0.83 %) |
| Feb 06 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 187.91 | 900 | 169,119 | 124,865 | 125.8 K to 124.9 K (-0.72 %) |
| Feb 06 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 186.70 | 12,951 | 2,417,952 | 125,765 | 138.7 K to 125.8 K (-9.34 %) |
| Feb 06 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 186.10 | 17,099 | 3,182,124 | 138,716 | 155.8 K to 138.7 K (-10.97 %) |
| Feb 06 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 184.99 | 1,300 | 240,487 | 155,815 | 157.1 K to 155.8 K (-0.83 %) |
| Jun 26 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 83.36 | 106,500 | 8,877,840 | 0 | |
| Jun 26 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 160.00 | 140,211 | 22,433,760 | 157,049 | 297.3 K to 157 K (-47.17 %) |
| Jun 26 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 83.36 | 106,500 | 8,877,840 | 297,260 | 190.8 K to 297.3 K (+55.83 %) |
| May 30 2018 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Sell | S | 105.61 | 1,644 | 173,623 | 6,000 | 7.6 K to 6 K (-21.51 %) |
| May 17 2018 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Grant | A | 0.00 | 1,644 | 0 | 7,644 | 6 K to 7.6 K (+27.40 %) |
| Feb 08 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | A | 155.57 | 73,046 | 11,363,766 | 73,046 | |
| Feb 08 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Grant | A | 0.00 | 31,498 | 0 | 214,563 | 183.1 K to 214.6 K (+17.21 %) |
| Feb 08 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Grant | A | 0.00 | 50,568 | 0 | 183,065 | 132.5 K to 183.1 K (+38.17 %) |
| Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 45.11 | 55,313 | 2,495,169 | 0 | |
| Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 48.74 | 44,250 | 2,156,745 | 0 | |
| Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 159.39 | 7,995 | 1,274,323 | 132,497 | 140.5 K to 132.5 K (-5.69 %) |
| Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 158.79 | 17,918 | 2,845,199 | 140,492 | 158.4 K to 140.5 K (-11.31 %) |
| Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 157.67 | 11,471 | 1,808,633 | 158,410 | 169.9 K to 158.4 K (-6.75 %) |
| Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 156.62 | 19,808 | 3,102,329 | 169,881 | 189.7 K to 169.9 K (-10.44 %) |
| Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 155.77 | 42,371 | 6,600,131 | 189,689 | 232.1 K to 189.7 K (-18.26 %) |
| Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 45.11 | 55,313 | 2,495,169 | 232,060 | 176.7 K to 232.1 K (+31.30 %) |
| Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 48.74 | 44,250 | 2,156,745 | 176,747 | 132.5 K to 176.7 K (+33.40 %) |
| Dec 11 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 143.39 | 5,198 | 745,341 | 132,497 | 137.7 K to 132.5 K (-3.78 %) |
| Dec 11 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 142.21 | 12,134 | 1,725,576 | 137,695 | 149.8 K to 137.7 K (-8.10 %) |
| Dec 11 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 141.35 | 87,578 | 12,379,150 | 149,829 | 237.4 K to 149.8 K (-36.89 %) |
| Dec 11 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 140.31 | 20,090 | 2,818,828 | 237,407 | 257.5 K to 237.4 K (-7.80 %) |
| Aug 08 2017 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Sell | S | 106.66 | 296 | 31,571 | 6,000 | 6.3 K to 6 K (-4.70 %) |
| Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 45.11 | 11,063 | 499,052 | 55,313 | |
| Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 154.05 | 700 | 107,835 | 257,392 | 258.1 K to 257.4 K (-0.27 %) |
| Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 153.24 | 5,000 | 766,200 | 258,092 | 263.1 K to 258.1 K (-1.90 %) |
| Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 152.25 | 5,363 | 816,517 | 263,092 | 268.5 K to 263.1 K (-2.00 %) |
| Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 45.11 | 11,063 | 499,052 | 268,455 | 257.4 K to 268.5 K (+4.30 %) |
| Jul 31 2017 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Sell | S | 108.73 | 1,304 | 141,783 | 6,296 | 7.6 K to 6.3 K (-17.16 %) |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 48.74 | 73,750 | 3,594,575 | 44,250 | |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 45.11 | 110,624 | 4,990,249 | 66,376 | |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 162.08 | 5,058 | 819,801 | 257,392 | 262.5 K to 257.4 K (-1.93 %) |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 161.43 | 17,255 | 2,785,475 | 262,450 | 279.7 K to 262.5 K (-6.17 %) |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 160.42 | 900 | 144,378 | 279,705 | 280.6 K to 279.7 K (-0.32 %) |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 159.34 | 3,500 | 557,690 | 280,605 | 284.1 K to 280.6 K (-1.23 %) |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 158.46 | 4,837 | 766,471 | 284,105 | 288.9 K to 284.1 K (-1.67 %) |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 157.42 | 700 | 110,194 | 288,942 | 289.6 K to 288.9 K (-0.24 %) |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 161.00 | 184,374 | 29,684,214 | 289,642 | 474 K to 289.6 K (-38.90 %) |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 48.74 | 73,750 | 3,594,575 | 474,016 | 400.3 K to 474 K (+18.43 %) |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 45.11 | 110,624 | 4,990,249 | 400,266 | 289.6 K to 400.3 K (+38.19 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 29.98 | 124,601 | 3,735,538 | 0 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 53.85 | 22,500 | 1,211,625 | 0 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 129.50 | 147,101 | 19,049,580 | 289,642 | 436.7 K to 289.6 K (-33.68 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 29.98 | 124,601 | 3,735,538 | 436,743 | 312.1 K to 436.7 K (+39.92 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 53.85 | 22,500 | 1,211,625 | 312,142 | 289.6 K to 312.1 K (+7.77 %) |
| May 18 2017 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Grant | A | 0.00 | 1,573 | 0 | 7,600 | 6 K to 7.6 K (+26.10 %) |
| Feb 15 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 88.39 | 100 | 8,839 | 306,645 | 306.7 K to 306.6 K (-0.03 %) |
| Feb 15 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 87.68 | 23,804 | 2,087,135 | 306,745 | 330.5 K to 306.7 K (-7.20 %) |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | A | 86.52 | 103,550 | 8,959,146 | 103,550 | |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Grant | A | 0.00 | 50,567 | 0 | 330,549 | 280 K to 330.5 K (+18.06 %) |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Grant | A | 0.01 | 17,895 | 179 | 279,982 | 262.1 K to 280 K (+6.83 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Option Exercise | M | 70.37 | 311 | 21,885 | 0 | |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Option Exercise | M | 70.37 | 311 | 21,885 | 0 |